Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Controlled Clinical Trial
. 2009 Sep;4(9):1459-64.
doi: 10.2215/CJN.02590409. Epub 2009 Aug 6.

Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study

Affiliations
Controlled Clinical Trial

Increased efficiency of hemodialysis with citrate dialysate: a prospective controlled study

Robert J Kossmann et al. Clin J Am Soc Nephrol. 2009 Sep.

Abstract

Background and objectives: A bicarbonate dialysate acidified with citrate (CD) has been reported to have local anticoagulant effect. This study examines the effect of CD on dialysis efficiency, measured as eKt/Vurea, and predialysis concentrations of BUN, creatinine, phosphate, and beta-2 microglobulin in chronic dialysis units.

Design, settings, participants, & measurements: Three outpatient chronic hemodialysis units with 142 patients were switched to CD for 6 mo. Using each patient's prior 6 mo on regular bicarbonate dialysate acidified by acetate (AD) as control, eKt/Vurea was compared with that of CD. Follow-up data for 7 mo after the study were collected from about one-half of the participants remaining on CD and the others returned to AD.

Results: eKt/Vurea, increased (P < 0.0001) from pre-CD value of 1.51 +/- 0.01 to 1.57 +/- 0.01 with CD. During CD use beta-2 microglobulin levels declined (P = 0.0001) from 28.1 +/- 10.0 to 25.9 +/- 10.0. Similarly, the concentrations of BUN, creatinine, and phosphate also decreased on CD (P < 0.008). In the poststudy period, eKt/Vurea for the patients staying on CD remained unchanged at 1.60 +/- 0.17 versus 1.59 +/- 0.18 (P = NS), whereas in those returning to AD the eKt/Vurea decreased from 1.55 +/- 0.20 to 1.52 +/- 0.17 (P < 0.0001).

Conclusions: Data suggest that CD use is associated with increased solute removal.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The dose of dialysis measured as eKt/Vurea (6 mo average values, n = 142).
Figure 2.
Figure 2.
Mean predialysis blood aluminum levels with regular dialysate and CD (n = 142).
Figure 3.
Figure 3.
The dose of dialysis as eKt/Vurea in low achieved dose patients at baseline (regular dialysate use). Values are during regular dialysate and CD uses and are averages ± SEM (n = 19).
Figure 4.
Figure 4.
Dialysis dose as eKt/Vurea in two groups of patients: those continuing on CD (solid line) for additional 7 mo (n = 69) and those switched back to regular dialysate (dashed line, n = 73). Values are mean ± SD.

Comment in

  • Dialysate ... Ho-hum!
    Golper TA, Ward RA. Golper TA, et al. Clin J Am Soc Nephrol. 2009 Sep;4(9):1403-4. doi: 10.2215/CJN.04940709. Epub 2009 Aug 20. Clin J Am Soc Nephrol. 2009. PMID: 19696215 No abstract available.

References

    1. Ahmad S, Callan R, Cole JJ, Blagg CR: Increased dialyzer reuse with citrate bicarbonate dialysate. Hemodial Int 9: 264–267, 2005 - PubMed
    1. Pawlak K, Naumnik B, Brzosko S, Pawlak D, Mysilieiec M: Oxidative stress—A link between endothelial injury, coagulation activation, and atherosclerosis in haemodialysis patients. Am J Nephrol 24: 154–161, 2004 - PubMed
    1. Ahmad S: Anticoagulation. In: Manual of Clinical Dialysis, 2nd ed., edited by Ahmad S.New York, Springer, 2009: 29–36
    1. Ahmad S, Callan R, Cole JJ, Blagg CR: Dialysate made from dry chemicals using citric acid increases dialysis dose. Am J Kidney Dis 35: 493–499, 2000 - PubMed
    1. Gotch FA, Keen M: Kinetic modeling in hemodialysis. In: Clinical Dialysis, 4th ed., edited by Nissenson AR, Fine RA.New York, McGraw Hill, 2005: 153–203

Publication types

MeSH terms

LinkOut - more resources